Find uplifting stories about heroes, innovations, and solutions
18 results for "hypertrophic cardiomyopathy"
A pharmaceutical breakthrough just opened doors for patients with a heart condition that's never had an approved treatment. Cytokinetics' drug Myqorzo succeeded in treating non-obstructive hypertrophic cardiomyopathy, doubling the number of people who could benefit from this therapy.
A precision medicine breakthrough offers teenagers with a dangerous inherited heart condition their first targeted therapy, dramatically reducing obstruction and potentially healing heart damage. The drug mavacamten could transform treatment for young patients who previously faced limited options beyond invasive surgery.
Scientists just pinpointed a microscopic protein region that keeps hearts beating steadily, opening doors to future treatments for devastating heart conditions. The breakthrough could help millions born with or developing life-threatening heart rhythm problems.
A new treatment for an inherited heart condition just cleared a major hurdle that could help thousands more patients access life-changing care. Cytokinetics announced their drug Myqorzo significantly improved symptoms for people with a less severe form of heart disease.
A breakthrough clinical trial offers the first successful treatment for patients with non-obstructive heart disease who've had zero approved therapies. The drug improved both quality of life and exercise capacity in people living with a challenging heart condition.
A precision medicine drug just gave teens with a dangerous inherited heart disease their first real treatment option beyond invasive surgery. The Philadelphia trial showed mavacamten dramatically reduced heart blockage and may even help hearts heal.
A renowned cardiologist says protecting your heart doesn't require complicated medical knowledge. Five key numbers and 30 minutes of movement four times weekly can dramatically reduce your risk of heart disease.
Scientists discovered that a common diabetes medication dramatically reduces heart failure in people carrying rare genetic variants for heart disease. The finding could transform preventive care for thousands at high genetic risk.
Former England cricketer James Taylor survived a near-fatal heart attack at 26 that ended his career. A decade later, he's building a fulfilling new life in coaching and helping others.
Researchers in India discovered a single gene that causes three major health conditions to occur together, opening doors for early detection and better treatment. The breakthrough could help doctors identify at-risk families before symptoms appear.
A heart condition once called a death sentence now has multiple FDA-approved treatments that are keeping patients alive and out of hospitals. Cardiac amyloidosis patients are being diagnosed earlier and living longer thanks to breakthrough medications approved in the past year.
William Goff survived leukemia as a baby, but chemotherapy damaged his heart. Two years ago, he received a life-saving transplant and now plays baseball again.
England cricketer James Taylor nearly died at 26 when his heart raced at 265 beats per minute during a match. A decade later, he's thriving as a coach and helping shape the next generation of players.
Thousands of Brazilians with a rare, life-threatening heart condition just gained access to a medication that cuts hospitalizations in half. The oral treatment offers hope to patients who have long faced limited options.
A cardiovascular researcher at the University of Central Florida has developed a revolutionary drug delivery system using targeted microscopic bubbles that could dramatically improve how heart disease is treated. The innovation addresses a major flaw in current treatments: doctors can't be sure medications actually reach the diseased heart tissue.
A trainee solicitor with a serious heart condition is attempting to break a Guinness World Record at the London Marathon while dressed as Captain Underpants. Archie Hunt is running to raise money for the children's hospital that treats his condition.
Researchers have identified a tiny protein region that keeps hearts beating steadily throughout our lives. The breakthrough could lead to treatments for devastating inherited heart diseases that affect thousands of families.
A Japanese startup just treated a heart failure patient using a simple catheter instead of open-heart surgery, injecting lab-grown heart muscle cells that could transform cardiac care. The patient in his 70s has already gone home.